Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Akili Inc - SIC # 3845 - ELECTROMEDICAL AND ELECTROTHERAPEUTIC APPARATUS
Ticker
Exchange
SIC #
Website
Latest Ticker
AKLI
Nasdaq
3845
https://www.akiliinteractive.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Akili Inc
Akili, Inc. (NASDAQ:AKLI) Q4 2022 Earnings Call Transcript
- Mar 13th, 2023 3:51 pm
Q4 2022 Akili Inc Earnings Call
- Mar 8th, 2023 1:32 pm
Akili Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
- Mar 7th, 2023 9:01 pm
Akili, Inc.'s (NASDAQ:AKLI) market cap up US$26m last week, benefiting both individual investors who own 26% as well as insiders
- Feb 8th, 2023 4:37 pm
Akili to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast on Tuesday, March 7 at 4:30 p.m. ET
- Feb 6th, 2023 12:00 pm
Akili to Participate in the Cowen 43rd Annual Health Care Conference
- Feb 2nd, 2023 12:00 pm
Akili to Champion Digital Therapeutics in Conjunction with J.P. Morgan Healthcare Conference
- Jan 6th, 2023 3:43 pm
Pivotal Trial of EndeavorRxⓇ in Adolescents with ADHD Shows Robust Improvements in Attention and Broader Clinical Outcomes
- Jan 5th, 2023 12:00 pm
Morgan Stanley Initiates Coverage On This Digital Therapeutics Stock With Attractive View
- Dec 29th, 2022 7:44 pm
Chamath Palihapitiya Stocks: 10 Stocks Picked in the Last 10 Years
- Dec 27th, 2022 4:05 pm
Akili Announces ADHD Expert Dr. Scott Kollins to Join as Chief Medical Officer
- Dec 1st, 2022 12:00 pm
Akili Third Quarter 2022 Earnings: EPS: US$1.38 (vs US$16.67 loss in 3Q 2021)
- Nov 19th, 2022 12:52 pm
Akili Reports Third Quarter 2022 Financial Results and Company Update
- Nov 10th, 2022 9:01 pm
Down More Than 50%: These 3 “Strong Buy” Stocks Are Too Cheap to Ignore
- Nov 1st, 2022 3:53 pm
Financial Industry Veteran Mary Hentges Joins Akili’s Board of Directors
- Oct 27th, 2022 11:00 am
Akili to Host Third Quarter 2022 Financial Results Conference Call and Webcast on Thursday, November 10 at 4:30 p.m. ET
- Oct 19th, 2022 11:00 am
Akili Launches EndeavorRx® Expedition - A Direct-to-Patient Product Registry
- Sep 21st, 2022 11:00 am
Akili to Participate in LifeSci Partners HealthTech Symposium
- Sep 19th, 2022 11:00 am
Akili 'took the last decade to clinically validate' its video game treatment for ADHD: CEO
- Aug 22nd, 2022 8:08 pm
Scroll